Special VHIO-CaixaResearch Scientific Seminar: VHIO Meet the Editors with Miguel Foronda, Associate Editor, Nature Cancer
Launched back in 2019, our VHIO – CaixaResearch [...]
Novel anti-PD-1 therapy, dostarlimab, approved as a new therapeutic avenue for recurrent or advanced endometrial cancer in Europe
Supported by the preliminary results* reported from [...]
The passing of a visionary in cancer research and clinical oncology: José Baselga, 1959-2021
José Baselga, a visionary leader in translational [...]
Peptomyc’s Omomyc-based therapy put to the clinical test: first-in-human phase I/II trial approved to assess the efficacy and safety of a novel Myc inhibitor
Laura Soucek, Principal Investigator of VHIO’s Mouse [...]
VHIO study reveals Myc-Wnt signaling cross-talk as a culprit of Myc-driven tumorigenesis in pancreatic islets
Mariano F. Zacarías Fluck, Research Associate of [...]
Newly appointed ESMO faculty: VHIO investigators join forces with other leading experts in oncology to deliver on ESMO’s Vision 2025
In parallel with the European Society for [...]
Spearheading next generation clinical trials: Cancer Core Europe’s design and development of data rich, dynamic studies in oncology
Incorporating experts from the seven European comprehensive [...]
Immune cells in cerebrospinal fluid: predictors of response to immunotherapy against brain metastasis
The analysis of immune cells infiltrating cerebrospinal [...]
AACR’s Project GENIE hits another phenomenal milestone: 9th public data set now released
Launched by the American Association for Cancer [...]
Driving nano-based approaches closer to the clinic: Vall d’Hebron leads pilot study to assess the efficacy of nanoparticles against pancreatic cancer
The Horizon 2020 funded NoCANTher European Consortium*, [...]